| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1217002A1 2-(4-pyridinyl)-benzofurans as metalloprotease inhibitors |
| 06/26/2002 | EP1217001A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 06/26/2002 | EP1217000A1 Inhibitors of factor Xa and factor VIIa |
| 06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
| 06/26/2002 | EP1216699A1 Transdermal system comprising a highly potent progestin |
| 06/26/2002 | EP1216685A2 Personal care compositions |
| 06/26/2002 | EP1216309A2 Methods for targeting rna molecules |
| 06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
| 06/26/2002 | EP1216250A1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists |
| 06/26/2002 | EP1216248A2 Triazolopyrimidine derivatives |
| 06/26/2002 | EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 06/26/2002 | EP1216246A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 06/26/2002 | EP1216245A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 06/26/2002 | EP1216239A1 Piperazine derivatives as 5-ht1b antagonists |
| 06/26/2002 | EP1216232A1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 06/26/2002 | EP1216231A2 INHIBITORS OF FACTOR Xa |
| 06/26/2002 | EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 06/26/2002 | EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 06/26/2002 | EP1216221A2 Rxr modulators with improved pharmacologic profile |
| 06/26/2002 | EP1216049A2 Methods for treating muscular dystrophy with bone marrow cells |
| 06/26/2002 | EP1216045A2 Vasopressin agonist formulation and process |
| 06/26/2002 | EP1216044A1 Compositions having improved stability |
| 06/26/2002 | EP1216043A1 Retard form containing alpha-lipoic acid (derivatives) |
| 06/26/2002 | EP1216041A2 High lipid diet |
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP1216033A1 Vasopressin antagonist formulation and process |
| 06/26/2002 | EP1216032A1 Oral controlled release formulations |
| 06/26/2002 | EP1216031A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1216025A1 Dispersion formulations containing lipase inhibitors |
| 06/26/2002 | EP1143998A4 Treatment of hypertension |
| 06/26/2002 | EP1049689B1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 06/26/2002 | EP1007072A4 Glial cell line-derived neurotrophic factor receptors |
| 06/26/2002 | EP0931067B1 D4 receptor selectivity piperazine derivatives |
| 06/26/2002 | EP0930878B1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 06/26/2002 | EP0906096B1 Use of hydroxyprolines for the manufacture of a medicament for inhibiting leukocyte invasion of tissues |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | EP0813537B1 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives |
| 06/26/2002 | EP0778026B1 Remedy for endotoxinemia and multiple organ failure induced thereby |
| 06/26/2002 | EP0771206B1 Hard tissue stimulating agent |
| 06/26/2002 | EP0693933B1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 06/26/2002 | EP0691814B1 Method and composition for treatment of osteoporosis |
| 06/26/2002 | EP0574391B1 Antibodies against the urokinase receptor and their use |
| 06/26/2002 | CN1355842A Methods for making proteins containing free cysteine residues |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355805A Thienopyrimidines compound |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355790A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 06/26/2002 | CN1355784A Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 06/26/2002 | CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 06/26/2002 | CN1355712A Use of antibodies against CD2O for treatment of graft versus host disease |
| 06/26/2002 | CN1355711A Method for inhibiting brain tumor growth |
| 06/26/2002 | CN1355708A HCV combination therapy containing ribavirin in association with antioxidants |
| 06/26/2002 | CN1355703A Therapeutical agent |
| 06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
| 06/26/2002 | CN1355697A IL-8 receptor antagonists |
| 06/26/2002 | CN1355695A Compounds useful in reducing level of insulin like growth factor-I (IGF-I) in blood |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355672A Method of increasing content of flavonoids and phenolic substances in plants |
| 06/26/2002 | CN1355015A Application of liposome preparation in transferring foreign DNA by testis injection |
| 06/26/2002 | CN1086702C 4-hydroxy-piperidine-derivatives |
| 06/26/2002 | CN1086583C Powder and pellet for strengening yang |
| 06/26/2002 | CN1086582C Anal fissure ointment and its preparing process |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410752 Tocopherol derivatives and method for preparation thereof |
| 06/25/2002 | US6410739 Indole derivatives as 5-HT1 agonists |
| 06/25/2002 | US6410733 Anticoagulants |
| 06/25/2002 | US6410731 Enhanced lipophilicity, bioavailability; made via a cascade radical 4+1 annulation including reacting a precursor with an arylisonitrile |
| 06/25/2002 | US6410728 Oxazolidinone chemotherapeutic agents |
| 06/25/2002 | US6410685 Reducing stress in mammals; obtain mammal, administer tripeptide, monitor mammal for reduction in products of stress response |
| 06/25/2002 | US6410599 Mixture of benzalkonium chloride, water and isopropanol |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410588 Use of cannabinoids as anti-inflammatory agents |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/25/2002 | US6410582 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 06/25/2002 | US6410573 Cardiovascular diseases; potassium channel modulator |
| 06/25/2002 | US6410568 Porphyrins and their use as photosensitizer |
| 06/25/2002 | US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 06/25/2002 | US6410555 Antiepileptic agents; headaches |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410552 Benzoether and related compositions and methods |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410550 Aryl fused azapolycyclic compounds |
| 06/25/2002 | US6410547 Phenylpyridine derivatives useful as phosphodiesterase inhibitors |
| 06/25/2002 | US6410544 Vision defects; administering pilocarpine |
| 06/25/2002 | US6410542 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410539 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 06/25/2002 | US6410536 Anticoagulants |
| 06/25/2002 | US6410535 Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance |
| 06/25/2002 | US6410534 Anticancer agents |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410513 Polypeptides |
| 06/25/2002 | US6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |